These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


870 related items for PubMed ID: 21567419

  • 1. Interference of replication between hepatitis B and C viruses in patients infected with HIV.
    Yang RR, Gui X, Chen XY, Zhu Y.
    J Med Virol; 2011 Jul; 83(7):1159-64. PubMed ID: 21567419
    [Abstract] [Full Text] [Related]

  • 2. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR, Mathur A, Mathur D, Udawat HP, Nepalia S, Nijhawan S, Mathur A.
    Trop Gastroenterol; 2007 Jul; 28(1):19-23. PubMed ID: 17896605
    [Abstract] [Full Text] [Related]

  • 3. Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virus.
    Boyd A, Lacombe K, Miailhes P, Gozlan J, Bonnard P, Molina JM, Lascoux-Combe C, Serfaty L, Gault E, Desvarieux M, Girard PM.
    J Viral Hepat; 2010 Jan; 17(1):65-76. PubMed ID: 19682317
    [Abstract] [Full Text] [Related]

  • 4. [Investigation of occult hepatitis B in HIV infected patients].
    Altınbaş A, Ergünay K, Calık Başaran N, Alp A, Turgut D, Hasçelik G, Uzun Ö, Unal S.
    Mikrobiyol Bul; 2011 Apr; 45(2):353-8. PubMed ID: 21644079
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.
    Chen X, He JM, Ding LS, Zhang GQ, Zou XB, Zheng J.
    Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454
    [Abstract] [Full Text] [Related]

  • 6. High rates of active hepatitis B and C co-infections in HIV-1 infected Cameroonian adults initiating antiretroviral therapy.
    Laurent C, Bourgeois A, Mpoudi-Ngolé E, Kouanfack C, Ciaffi L, Nkoué N, Mougnutou R, Calmy A, Koulla-Shiro S, Ducos J, Delaporte E.
    HIV Med; 2010 Jan; 11(1):85-9. PubMed ID: 19659944
    [Abstract] [Full Text] [Related]

  • 7. Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells.
    Eyre NS, Phillips RJ, Bowden S, Yip E, Dewar B, Locarnini SA, Beard MR.
    J Hepatol; 2009 Sep; 51(3):446-57. PubMed ID: 19596477
    [Abstract] [Full Text] [Related]

  • 8. Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study).
    Diop-Ndiaye H, Touré-Kane C, Etard JF, Lô G, Diaw P, Ngom-Gueye NF, Gueye PM, Ba-Fall K, Ndiaye I, Sow PS, Delaporte E, Mboup S.
    J Med Virol; 2008 Aug; 80(8):1332-6. PubMed ID: 18551596
    [Abstract] [Full Text] [Related]

  • 9. Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts.
    Schleicher S, Schieffer M, Jürgens S, Wehner HD, Flehmig B.
    Ig Sanita Pubbl; 2005 Aug; 61(5):435-50. PubMed ID: 17214028
    [Abstract] [Full Text] [Related]

  • 10. Co-infection with hepatitis viruses among HIV-infected individuals at a tertiary care centre in South India.
    Kosaraju K, Padukone S, Bairy I.
    Trop Doct; 2011 Jul; 41(3):170-1. PubMed ID: 21676983
    [Abstract] [Full Text] [Related]

  • 11. Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study.
    Dong Y, Qiu C, Xia X, Wang J, Zhang H, Zhang X, Xu J.
    Arch Virol; 2015 Apr; 160(4):929-36. PubMed ID: 25616842
    [Abstract] [Full Text] [Related]

  • 12. Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem?
    Rodríguez-Torres M, Gonzalez-Garcia J, Bräu N, Solá R, Moreno S, Rockstroh J, Smaill F, Mendes-Correa MC, DePamphilis J, Torriani FJ, APRICOT Investigators.
    J Med Virol; 2007 Jun; 79(6):694-700. PubMed ID: 17457912
    [Abstract] [Full Text] [Related]

  • 13. Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference.
    Jardi R, Rodriguez F, Buti M, Costa X, Cotrina M, Galimany R, Esteban R, Guardia J.
    Hepatology; 2001 Aug; 34(2):404-10. PubMed ID: 11481626
    [Abstract] [Full Text] [Related]

  • 14. Virological significance of low-level hepatitis B virus infection in patients with hepatitis C virus associated liver disease.
    Tanaka T, Inoue K, Hayashi Y, Abe A, Tsukiyama-Kohara K, Nuriya H, Aoki Y, Kawaguchi R, Kubota K, Yoshiba M, Koike M, Tanaka S, Kohara M.
    J Med Virol; 2004 Feb; 72(2):223-9. PubMed ID: 14695663
    [Abstract] [Full Text] [Related]

  • 15. Prevalence of hepatitis B virus and hepatitis C virus co-infection with human immunodeficiency virus in Thai patients: a tertiary-care-based study.
    Sungkanuparph S, Vibhagool A, Manosuthi W, Kiertiburanakul S, Atamasirikul K, Aumkhyan A, Thakkinstian A.
    J Med Assoc Thai; 2004 Nov; 87(11):1349-54. PubMed ID: 15825712
    [Abstract] [Full Text] [Related]

  • 16. Multiple genotypes and subtypes of hepatitis B and C viruses in Belarus: similarities with Russia and western European influences.
    Olinger CM, Lazouskaya NV, Eremin VF, Muller CP.
    Clin Microbiol Infect; 2008 Jun; 14(6):575-81. PubMed ID: 18373690
    [Abstract] [Full Text] [Related]

  • 17. Low replication and variability of HBV pre-core in concomitant infection with hepatitis B and hepatitis C viruses.
    De Mitri MS, Morsica G, Cassini R, Bagaglio S, Andreone P, Bianchi G, Loggi E, Bernardi M.
    Arch Virol; 2007 Feb; 152(2):395-404. PubMed ID: 16953307
    [Abstract] [Full Text] [Related]

  • 18. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy.
    Cohen Stuart JW, Velema M, Schuurman R, Boucher CA, Hoepelman AI.
    J Med Virol; 2009 Mar; 81(3):441-5. PubMed ID: 19152397
    [Abstract] [Full Text] [Related]

  • 19. Hepatitis C (HCV) genotype and viral titer distribution among Argentinean hemophilic patients in the presence or absence of human immunodeficiency virus (HIV) co-infection.
    Picchio GR, Nakatsuno M, Boggiano C, Sabbe R, Corti M, Daruich J, Pérez-Bianco R, Tezanos-Pinto M, Kokka R, Wilber J, Mosier D.
    J Med Virol; 1997 Jun; 52(2):219-25. PubMed ID: 9179772
    [Abstract] [Full Text] [Related]

  • 20. Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus.
    Seed CR, Kiely P, Keller AJ.
    Intern Med J; 2005 Oct; 35(10):592-8. PubMed ID: 16207258
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 44.